An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings

Journal of Hospital Infection

Volumn 64, Issue 3, 2006, Pages 303-305

  Longo, B ^a   Pantosti, A ^a   Luzzi, I ^a   Placanica, P ^b   Gallo, S ^b   Tarasi, A ^b   Di Sora, F ^b   Monaco, M ^a   Dionisi, A M ^a   Volpe, I ^b   Montella, F ^b   Cassone, A ^a   Rezza, G ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; IMIPENEM; LINEZOLID; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ARTERY CATHETERIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BLOOD SAMPLING; BRONCHOSCOPY; CENTRAL VENOUS CATHETER; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; DECUBITUS; ENTERIC FEEDING; HUMAN; INTENSIVE CARE UNIT; ITALY; LETTER; LUNG LAVAGE; MEDICAL RECORD REVIEW; NONHUMAN; NOSE SMEAR; PARENTERAL NUTRITION; RISK FACTOR; THROAT CULTURE; TRACHEOSTOMY; WOUND;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; RISK FACTORS; ROME; TRACHEOSTOMY;

EID: 33749255184     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.07.010     Document Type: Letter

References (8)

1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 16th informational supplement. M100-S16 (2006), CLSI, Wayne, PA
2. Gales A.C., Reis O.A., and Jones R.N. Contemporary assessment of antimicrobial susceptibility testing methods for polimyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39 (2001) 183-190
3. Mah M.W., Memish Z.A., Cunningham G., and Bannatyne R.B. Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheostomy. Am J Infect Control 29 (2001) 284-288
4. Cefai C., Richards J., Gould F.K., and McPaeke P. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect 15 (1990) 177-182
5. Van Looveren M., Goossens H., and ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10 (2004) 684-704
6. Coelho J., Woodford N., Afzal-Shah M., and Livermore D. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 50 (2006) 756-758
7. Bertini A., Giordano A., Varesi P., Villa L., Mancini C., and Carattoli A. First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. Antimicrob Agents Chemother 50 (2006) 2268-2269
8. Rhomberg P.R., Jones R.N., and MYSTIC Program (USA) Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis 47 (2003) 365-372